These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38928644)

  • 1. Hypovitaminosis D and Leukocytosis to Predict Cardiovascular Abnormalities in Children with Kawasaki Disease: Insights from a Single-Center Retrospective Observational Cohort Study.
    Rigante D; De Rosa G; Delogu AB; Rotunno G; Cianci R; Di Pangrazio C; Sodero G; Basile U; Candelli M
    Diagnostics (Basel); 2024 Jun; 14(12):. PubMed ID: 38928644
    [No Abstract]   [Full Text] [Related]  

  • 2. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB; Zhao S; Liu ZY; Xu YY; Deng F
    Ann Med; 2023; 55(2):2264315. PubMed ID: 37870383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities?
    Stagi S; Rigante D; Lepri G; Matucci Cerinic M; Falcini F
    Clin Rheumatol; 2016 Jul; 35(7):1865-72. PubMed ID: 25994612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
    Wu S; Liao Y; Sun Y; Zhang CY; Zhang QY; Yan H; Qi JG; Liu XQ; Chen YH; Wang YL; Li XY; Jin HF; Du JB
    World J Pediatr; 2020 Dec; 16(6):607-613. PubMed ID: 32232677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.
    Zhang X; He Y; Shao Y; Hang B; Xu Z; Chu M
    Pediatr Rheumatol Online J; 2021 Jun; 19(1):96. PubMed ID: 34174872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
    Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
    Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G; Jianming L; Suqian T; Dong Q; Shuang L; Jin Z
    BMC Pediatr; 2022 Jan; 22(1):29. PubMed ID: 34996405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
    Li SY; Ding Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Demographic, Clinical, and Echocardiographic Features Between Complete and Incomplete, and Early and Late Presenters of Kawasaki Disease: A 10-Year Single-Center Experience.
    Kolko N; Bhat YA; Al Mesned A; Al Qwaee A; Al Akhfash A; Alhobani M; Al Anazi I
    Cureus; 2023 Sep; 15(9):e45819. PubMed ID: 37876391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days.
    Hu YC; Liu HM; Lin MT; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
    Front Pediatr; 2019; 7():158. PubMed ID: 31069204
    [No Abstract]   [Full Text] [Related]  

  • 15. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 16. Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease.
    Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Byeon JH; Sohn S; Hong YM; Jang GY; Lee JK;
    Pediatr Cardiol; 2015 Feb; 36(2):438-44. PubMed ID: 25266886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group.
    Yilmaz Ciftdogan D; Ekemen Keles Y; Cetin BS; Dalgic Karabulut N; Emiroglu M; Bagci Z; Buyukcam A; Erdeniz EH; Arga G; Yesil E; Cakici O; Karbuz A; Sahbudak Bal Z; Kara SS; Ozer A; Metin Akcan O; Elmas Bozdemir S; Anil AB; Uygun H; Kilic O; Hancerli Torun S; Umit Z; Sutcu M; Ozgokce Ozmen B; Karaoglu Asrak H; Alkan G; Kara Aksay A; Ugur C; Birbilen AZ; Bursal Duramaz B; Akyuz Ozkan E; Burakay O; Yildirim Arslan S; Karadag Oncel E; Celik SF; Kilic AO; Ozen S; Sarikaya R; Demirkol D; Arslan G; Turel O; Sert A; Sari E; Orbak Z; Sahin IO; Varan C; Akturk H; Tuter Oz SK; Durak F; Oflaz MB; Kara M; Karpuz D; Talip Petmezci M; Hatipoglu N; Oncel S; Turgut M; Elmali F; Somer A; Kuyucu N; Dinleyici EC; Kurugöl Z; Ciftci E; Kara A
    Eur J Pediatr; 2022 May; 181(5):2031-2043. PubMed ID: 35129668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J; Liu P; Hu W; Xu Y; Deng J
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.